Labros Meimetis secures $3.2 million NIH grant to research immune-boosting treatment for advanced prostate cancer
Labros Meimetis, PhD is awarded a five-year, $3.2 million grant from the National Institutes of Health, National Cancer Institute to further develop a targeted treatment for advanced prostate cancer that combines radiation induced tumor-killing and immune-boosting therapies.